Verbascoside Protects Pancreatic β-Cells against ER-Stress

Substantial epidemiological evidence indicates that a diet rich in polyphenols protects against developing type 2 diabetes. The phenylethanoid glycoside verbascoside/acteoside, a widespread polyphenolic plant compound, has several biological properties including strong antioxidant, anti-inflammatory...

Full description

Saved in:
Bibliographic Details
Published inBiomedicines Vol. 8; no. 12; p. 582
Main Authors Galli, Alessandra, Marciani, Paola, Marku, Algerta, Ghislanzoni, Silvia, Bertuzzi, Federico, Rossi, Raffaella, Di Giancamillo, Alessia, Castagna, Michela, Perego, Carla
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 08.12.2020
MDPI
Subjects
Online AccessGet full text
ISSN2227-9059
2227-9059
DOI10.3390/biomedicines8120582

Cover

More Information
Summary:Substantial epidemiological evidence indicates that a diet rich in polyphenols protects against developing type 2 diabetes. The phenylethanoid glycoside verbascoside/acteoside, a widespread polyphenolic plant compound, has several biological properties including strong antioxidant, anti-inflammatory and neuroprotective activities. The aim of this research was to test the possible effects of verbascoside on pancreatic β-cells, a target never tested before. Mouse and human β-cells were incubated with verbascoside (0.8–16 µM) for up to five days and a combination of biochemical and imaging techniques were used to assess the β-cell survival and function under normal or endoplasmic reticulum (ER)-stress inducing conditions. We found a dose-dependent protective effect of verbascoside against oxidative stress in clonal and human β-cells. Mechanistic studies revealed that the polyphenol protects β-cells against ER-stress mediated dysfunctions, modulating the activation of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) branch of the unfolded protein response and promoting mitochondrial dynamics. As a result, increased viability, mitochondrial function and insulin content were detected in these cells. These studies provide the evidence that verbascoside boosts the ability of β-cells to cope with ER-stress, an important contributor of β-cell dysfunction and failure in diabetic conditions and support the therapeutic potential of verbascoside in diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines8120582